Adenosine A(2A) receptor antagonists act at the hyperoxic phase to confer protection against retinopathy

BACKGROUND: Retinopathy of prematurity (ROP) remains a major cause of childhood blindness and current laser photocoagulation and anti-VEGF antibody treatments are associated with reduced peripheral vision and possible delayed development of retinal vasculatures and neurons. In this study, we advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Rong, Zhang, Shuya, Gu, Xuejiao, Ge, Yuanyuan, Zhong, Dingjuan, Zhou, Yuling, Tang, Lingyun, Liu, Xiao-Ling, Chen, Jiang-Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069809/
https://www.ncbi.nlm.nih.gov/pubmed/30134834
http://dx.doi.org/10.1186/s10020-018-0038-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069809/
https://www.ncbi.nlm.nih.gov/pubmed/30134834
http://dx.doi.org/10.1186/s10020-018-0038-1

Ejemplares similares